Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Evolving impact of long-term survival results on metastatic melanoma treatment

VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

IJMS, Free Full-Text

Neoadjuvant pembrolizumab administered before surgery improves outcomes of melanoma patients: phase 2 clinical trial findings

Cancers, Free Full-Text

Neoadjuvant and adjuvant treatment received by patients with mucosal

Cancers, Free Full-Text

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Advances in Adjuvant Therapy For Cutaneous Melanoma: Implications for Clinical Practice

Prognostic and predictive value of CTC level in neoadjuvant, adjuvant

ESMO22 Highlights on neoadj. vs adjuvant pembrolizumab in resected stage III-IV melanoma:SWOG S1801

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma

Neoadjuvant Immunotherapy: Leveraging the Immune System to Treat Early-Stage Disease

Frontiers Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer